Perrigo (PRGO) Interest & Investment Income (2023 - 2026)
Perrigo (PRGO) reported Interest & Investment Income of -$40.8 million for Q1 2026, down 4.62% year-over-year from -$42.8 million in Q1 2025, and up 5.77% quarter-over-quarter from -$43.3 million in Q4 2025.
Perrigo (PRGO) Interest & Investment Income (2023 - 2026) Analysis & Trends
Perrigo (PRGO) has 4 years of Interest & Investment Income data on file, last reported at -$40.8 million in Q1 2026.
- Interest & Investment Income for Q1 2026 came in at -$40.8 million, down 4.62% year-over-year; the trailing twelve-month figure through Mar 2026 was -$164.3 million (up 10.61% YoY), and the FY2025 annual result was -$162.5 million, up 13.47% from the prior year.
- Interest & Investment Income rose to -$40.8 million in Q1 2026 per PRGO's latest filing, from -$43.3 million in the prior quarter.
- Over five years, Interest & Investment Income peaked at -$39.0 million in Q1 2025 and troughed at -$57.6 million in Q3 2024.
- A 4-year average of -$43.4 million and a median of -$43.0 million in 2024 frame the typical range for Interest & Investment Income.
- The sharpest annual moves came in 2024 and 2025: Interest & Investment Income plunged 32.41% in 2024, then advanced 29.51% in 2025.
- A 4-year view of Interest & Investment Income shows it stood at -$42.7 million in 2023, then slipped by 0.94% to -$43.1 million in 2024, then fell by 0.46% to -$43.3 million in 2025, then advanced by 5.77% to -$40.8 million in 2026.
- Business Quant data shows PRGO's Interest & Investment Income at -$40.8 million in Q1 2026, -$43.3 million in Q4 2025, and -$40.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | 41.80 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | 3.45 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 28.10 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | 8.54 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 4.97 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | - |
| 10 | Perrigo | 1.55 Bn | 1.19 Bn | 325.50 Mn | -40.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | -40.80 Mn |
| Dec 31, 2025 | -43.30 Mn |
| Sep 27, 2025 | -40.60 Mn |
| Jun 28, 2025 | -39.60 Mn |
| Mar 29, 2025 | -39.00 Mn |
| Dec 31, 2024 | -43.10 Mn |
| Sep 28, 2024 | -57.60 Mn |
| Jun 29, 2024 | -44.10 Mn |
| Mar 30, 2024 | -43.00 Mn |
| Dec 31, 2023 | -42.70 Mn |
| Sep 30, 2023 | -43.50 Mn |
| Jul 1, 2023 | -44.00 Mn |